Alternative clinical end points in rectal cancer--are we getting closer?
about
Neoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical TrialsMeta-analysis of oncological outcome after abdominoperineal resection or low anterior resection for lower rectal cancerChemoradiation as definitive treatment for primary squamous cell cancer of the rectum.Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost.Initial results of a randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short-course radiotherapy or long-term chemoradiotherapy, both with delayed surgery.Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy.Chemotherapy Alone for Patients With Stage II/III Rectal Cancer Undergoing Radical SurgeryMultidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future.Surgical issues in locally advanced rectal cancer treated by preoperative chemoradiotherapy.Preoperative chemoradiation for locally advanced rectal cancer: comparison of three radiation dose and fractionation schedules.Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study.Selective fraction of Scutellaria baicalensis and its chemopreventive effects on MCF-7 human breast cancer cells.Colorectal Cancer Association of Canada consensus meeting: raising the standards of care for early-stage rectal cancer.Surgical oncology issues in locally advanced rectal cancer.Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis.MRI-based treatment of rectal cancer: is prognostication of the recurrence risk solid enough to render radiation redundant?Survival analysis in rectal carcinoma after neoadjuvant chemoradiation: various methods with different results.Improved local control of rectal cancer reduces distant metastases.Comparison of long-term survival outcome of operative vs nonoperative management of recurrent rectal cancer.Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation.Preoperative intensified radiochemotherapy for rectal cancer: experience of a single institution.Innovations in Clinical Trial Design in the Era of Molecular Profiling.Addition of platinum derivatives to neoadjuvant single-agent fluoropyrimidine chemoradiotherapy in patients with stage II/III rectal cancer: protocol for a systematic review and meta-analysis (PROSPERO CRD42017073064).Use of Preoperative Magnetic Resonance Imaging to Select Patients with Rectal Cancer for Neoadjuvant Chemoradiation--Interim Analysis of the German OCUM Trial (NCT01325649).Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy.Preoperative Intensity-modulated Chemoradiation Therapy with Simultaneous Integrated Boost in Rectal Cancer: 2-year Follow-up Results of Phase II Study.MRI-Based Indications for Neoadjuvant Radiochemotherapy in Rectal Carcinoma: Interim Results of a Prospective Multicenter Observational Study
P2860
Q26796253-C7AFE2E0-CC16-4E39-98F4-F89FA15D60C3Q26863687-49A6D2DD-DDDC-4602-81CE-F6CFC8A3E0A0Q33772521-3E2CFC6D-64BA-4053-962C-5E1DAEF513CCQ34156692-99800BCA-6C6C-43C5-9897-C1C1E7E7CF2EQ34632095-8175F29B-0935-40DE-9DFD-0061544B10BFQ35779456-339382C6-0564-43A6-B49F-1AF9D512CDECQ35820586-303FD3F4-4161-4628-8DBF-55CC1CB4D034Q35920508-2A51D546-F396-49F4-B1C3-D72AD8DF2520Q36514882-02446E54-70D1-4F9C-89B0-D060EC4621D2Q37079063-05FB1C91-00AC-42A7-B5BF-77D7B8799F13Q37129814-CFC97175-6C08-475C-8DAE-115002A5C6FAQ37461123-A13D0C82-9406-4DE6-BDC9-2292DCEF829EQ37479079-A6D59357-B483-4E44-9B52-262B72FA564FQ37980472-29498F12-EDE3-491A-8BA1-2F00AD8F260DQ37995506-864C8689-34C8-4633-BEB5-C7EF51F4DCB8Q38134007-26B0AAC4-39D0-46F6-9B5F-4F2843D46D73Q38668745-DCC18D25-9E54-44A8-8B76-9B91E425DE2EQ43914524-096C5E48-2114-4D2F-B4D3-33E824E0B0A7Q44636924-AF34E3FA-B8E1-400D-A8DE-C7A489BF2DAAQ44717104-63CFE72A-DF90-4C53-948B-AED248A97F18Q44801406-01E312C5-CA0D-49CF-9EAD-766BD1386903Q45059047-71C79633-0FE4-4B6F-944F-B0A072F054D5Q47718910-1937F91C-70D3-46E4-98A0-8BE415D41697Q48106528-829260DA-A7B2-4CA2-BF32-D9C79D181423Q48335407-D7F710EE-1822-45F6-892C-23B79CCCA75BQ55383754-F3C50161-7273-455D-AD02-9C8872CB9C60Q58028708-9E3A7128-D50E-4B82-815A-89C78B6D29AF
P2860
Alternative clinical end points in rectal cancer--are we getting closer?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Alternative clinical end points in rectal cancer--are we getting closer?
@ast
Alternative clinical end points in rectal cancer--are we getting closer?
@en
type
label
Alternative clinical end points in rectal cancer--are we getting closer?
@ast
Alternative clinical end points in rectal cancer--are we getting closer?
@en
prefLabel
Alternative clinical end points in rectal cancer--are we getting closer?
@ast
Alternative clinical end points in rectal cancer--are we getting closer?
@en
P2093
P356
P1433
P1476
Alternative clinical end points in rectal cancer--are we getting closer?
@en
P2093
R Glynne-Jones
S Mawdsley
P304
P356
10.1093/ANNONC/MDL173
P577
2006-08-01T00:00:00Z